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Comparative analysis of metabolic pathways in different genomes
yields important information on their evolution, on pharma-
cological targets and on biotechnological applications. In this
study on glycolysis, three alternative ways of comparing bio-
chemical pathways are combined: (1) analysis and comparison
of biochemical data, (2) pathway analysis based on the concept of
elementary modes, and (3) a comparative genome analysis of
17 completely sequenced genomes. The analysis reveals a sur-
prising plasticity of the glycolytic pathway. Isoenzymes in
INTRODUCTION
Sequence alignment is a well-established tool for investigating
and comparing nucleic acids from different species and for
identifying characteristic gaps, insertions and dissimilarities. The
availability of full genomic sequences and the increasing body of
biochemical data open up higher-order possibilities for com-
parative analysis [1,2]. The alignment of biochemical pathways
from different species is an important step towards a more global
comparison from a physiological viewpoint.
Here we present a detailed comparison of the glycolytic
pathway, including potential by-passes and species-specific en-
zyme sets, in different species. The recognition of such differences
is interesting for biotechnology (the identification of alternative
enzymes) and pharmacology (differences in drug targets). We
extend and combine biochemical data with elementary-mode
analysis of substrate fluxes, comparative genome analysis and
pathway alignment to reveal a much greater variety in glycolysis
than assumed in textbook standard knowledge, including impli-
cations for evolution and biotechnology.
Some other methods have been suggested to permit large-scale
comparisons of genomic data and pathways, notably clusters of
orthologous sequences [3] and the application of related enzyme
clusters [4] ; recent analyses have examined different genomic
aspects of glycolysis [2,5].
Whereas these approaches stress the genomic nature of the
data exploited for the comparison, our pathway alignment
focuses more on the biochemical capacity of the organisms
compared. Attempts in this biochemical direction have already
been made [6,7]. However, we show here how the use of
complementary data and tools extends the biochemical approach
and improves the predictive power of such efforts. The avail-
ability (reviewed in [1]) of full genomic sequences is exploited;
pathway fluxes and by-passes that use the identified enzymes are
tested for consistency by algebraic methods developed for this
Abbreviations used: PEP, phosphoenolpyruvate ; PPP, pentose phosphate pathway.
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different species are identified and compared; deviations from
the textbook standard are detailed. Several potential phar-
macological targets and by-passes (such as the Entner–Doudoroff
pathway) to glycolysis are examined and compared in the
different species. Archaean, bacterial and parasite specific adap-
tations are identified and described.
Key words: elementary modes, glycolysis, genome comparison,
isoenzymes, sequence analysis.
purpose [8]. Pathway alignment is greatly facilitated by the avail-
ability of databases on the World Wide Web (e.g. TIGR,
http:}}www.tigr.org; ExPasy, http:}}www.expasy.ch; KEGG,
http : } } www.tokyo-center.genome.ad.jp } kegg } kegg4.html ;
WIT, http:}}wit.mcs.anl.gov}WIT2}). However, as databases
are based on automated methods that include pre-formed path-
way charts, these automated predictions are here further refined
for an accurate analysis.
We combine our strategies for a systematic comparison of
glycolysis, alternative pathways such as the Entner–Doudoroff
pathway, and several functionally related enzymes such as
pyruvate dehydrogenase. We compare this part of the metabolic
chart in 16 completely sequenced prokaryotes as well as yeast.
MATERIALS AND METHODS
For the analysis of the glycolytic enzymes, species-specific
biochemical evidence from known experimental data and litera-
ture was collected.
Available completely sequenced genomes were extensively
cross-compared for a better identification of all encoded gly-
colytic enzymes in these organisms. Gene duplications, replace-
ment by unrelated sequences (non-orthologous displacement ; see
[1]) and gene neighbourhood were taken into account. We used
detailed sequence analysis protocols as described and reviewed
previously [1].
Phylogenetic analysis was applied for a further analysis of
gene duplication events and to clarify substrate specificities of the
encoded enzymes.
In the pathway analysis of glycolysis, we applied methods to
calculate elementary flux modes as described in [8,9]. For these
calculationswe used the programsEMPATH(J.Woods, personal
communication) and METATOOL [10] ; both programs are
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available from ftp:}}bmsdarwin.brookes.ac.uk}pub}mca}
software}ibmpc).
RESULTS AND DISCUSSION
Biochemical analysis of the pathway plasticity of glycolysis
After collection of relevant literature and databases, and ex-
tension of this by detailed sequence analysis, the biochemical
analysis examines the following questions : Besides the standard
pathway, which alternatives are available and how do these
alternatives compare? Which enzyme sets are involved? Where
are organism-specific, in particular parasite-specific, adaptations?
In a number of bacteria (including Escherichia coli), glucose is
anaerobically converted into pyruvate by the ‘standard’ gly-
colytic pathway as known and determined in higher organisms
including humans; at least some experimental evidence for this is
available. An initial indication for this is the ability to grow on
glucose as sole carbon source; a detailed study for different
sugars in Haemophilus influenzae has been done [11], and for
glucose in Treponema hyodysenteriae [12].
However, this does not mean that the presence of each
glycolytic enzyme was directly determined biochemically. Table
1 gives an overview of glycolytic enzymes that were characterized
directly biochemically, either in the species compared or in close
relatives. Additional biochemical evidence is available from
metabolite-tracing experiments and less direct data (some of this
is summarized on our Web site http:}}www.bork.embl-
heidelberg.de}Genome}glycolyticjenzymes). Nevertheless, most
of the specific glycolytic enzymes from completely sequenced
organisms have not been characterized in biochemical detail. For
example, little is known about the biochemical capabilities of
parasites such as Treponema pallidum and the obligate intra-
cellular Chlamydia trachomatis, respectively because of difficulties
in cultivating them continuously in itro and because their
metabolism has to be studied against the overwhelming back-
ground of the host cell metabolism [13]. Chlamydia species are
considered to be energy parasites, depending on their hosts to
Table 1 Biochemical characterization of glycolytic enzymes in various species (data from the literature)
Species Enzyme
Borrelia burgdorferi Triose-phosphate isomerase, phosphoglycerate kinase [34] ; glyceraldehyde-3-phosphate dehydrogenase [35]
Bacillus subtilis Phosphopyruvate hydratase, fructose bisphosphate aldolase A, phosphoglycerate kinase, glyceraldehyde-3-phosphate dehydrogenase, pyruvate dehydrogenase (B,
C and D subunits) [36] ; phosphofructokinase B [37] ; glucokinase [27] glucokinase yajF (measured for the homologous sequence from Streptomyces coelicor
[26a])
Chlamydia trachomatis Phosphoglucoisomerase (measured in Chlamydia psittaci [14])
Escherichia coli Standard glycolysis reviewed in [25] ; class I aldolase (EC2097) [30]
Haemophilus influenzae PEP phosphotransferase system [38] ; phosphoglucoisomerase [39]
Helicobacter pylori Glucose-6-phosphate dehydrogenase, 6-phosphogluconolactonase, 6-phosphogluconate dehydratase, 2-keto-3-deoxy-6-phosphogluconic acid aldolase, triose-
phosphate isomerase glucokinase [40] ; pyruvate synthase [32]
Mycoplasma genitalium,
M. pneumoniae
PEP phosphotransferase system, phosphoglucoisomerase, phosphofructokinase, fructose bisphosphate aldolase, triose-phosphate isomerase, glyceraldehyde 3-
phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, phosphopyruvate hydratase, pyruvate kinase, pyruvate dehydrogenase [15]
Methanococcus jannaschii Phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate mutase, phosphoglycerate kinase, triose-phosphate isomerase, fructose
bisphosphate aldolase, phosphoglucoisomerase (all measured in the related Methanococcus maripaludis [41]) ; class I aldolase activity has been measured in
Halobacteria [42] ; pyruvate synthase [43] ; dihydrolipoamide dehydrogenase A (MJ0636) (measured in the Haloferax volcanii homologue [44])
Mycobacterium tuberculosis Polyphosphate glucokinase, using ATP or polyphosphate as phospho donor [45] ; pyruvate dikinase measured in the related (high-GC, Gram-positive)
Propionibacterium shermanii [46]
Pyrococcus horikoschii Glucokinase, phosphoglucoisomerase, fructose bisphosphate aldolase (all measured in Pyrococcus furiosus ; the glucokinase is ADP dependent [23]) ;
glyceraldehyde-3-phosphate oxidoreductase (measured in P. furiosus [26])
Synechocystis Glyceraldehyde-3-phosphate dehydrogenase [47]
Saccharomyces cerevisiae Standard glycolysis (reviewed in [48])
generate ATP, because no metabolic pathway that results in the
generation of energy could be detected [14]. Some experiments
indicate that glucose can be degraded to CO
#
via the pentose
phosphate pathway (PPP) and by either glycolysis or the Entner–
Doudoroff pathway, although with a very low, hardly detectable
rate [14].
To obtain a better overview of the glycolytic enzymes present
in the different organisms, the biochemical analysis is extended
by an analysis of the different compounds, the use of
databases (e.g. TIGR, ExPasy, KEGG, and WIT) and
sequence searches (e.g. http:}}www.ncbi.nlm.nih.gov}BLAST},
http:}}dove.embl-heidelberg.de}Blast2). Biochemical function,
sequence-based enzyme comparisons and detailed enzyme
specificities (see also details available on our Web site) are made
more accurate by a careful comparison of domain architecture,
detection of duplication and gene displacement events, operon
organization and gene families. This is more exact than in
database overviews that use copious genome data but rely
strongly on an automated assignment of enzyme functions by
reciprocal gene similarities.
Summarizing these analyses, the flow from glucose 6-phos-
phate onwards presents a relatively well-conserved region of the
glycolytic pathway (Scheme 1). However, for a number of other
organisms several glycolytic enzymes are missing, according to
comparative sequence analysis and}or biochemical data. As an
example, we mention the absence of phosphofructokinase and
aldolase activity in Mycoplasma hominis [15] or the apparent lack
of genes encoding phosphofructokinase and pyruvate kinase in
Helicobacter pylori, a causative agent of stomach ulcers and
chronic ulcerative gastritis [16].
Alternative methods of processing glucose to pyruvate can be
compared (Scheme 1). In glycolysis (shown as the central
pathway), two molecules of triose are derived from one of
hexose; the energy yield is 2 mol of ATP}mol of glucose. The
complete glycolytic pathway is present in E. coli. This is also true
in most eukaryotic (including human) cells. However, a first
variation concerns the route of transfer of glucose into the cell.
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Scheme 1 Pathway plasticity incorporating genomic and biochemical data for variants of the glycolytic pathway
Alternative routes to the glycolytic pathway (centre) found in various species as shorter by-passes (top) or variant pathways (bottom) are shown. Paths and species examples are described on
the left. Arrows symbolize the substrate flux of the enzymic reactions. The release or consumption of ATP, ADP, NAD(P)(H), Pi and water is indicated. Enzyme numbers and names are as given
and summarized in Table 2. Hexokinase, EC 2.7.1.1 (shown, typical for the standard pathway in higher organisms) is replaced by glucokinase (EC 2.7.1.2) in prokaryotes. Phosphoglycerate mutase
(EC 5.4.2.1) is located after phosphoglycerate kinase (EC 2.7.2.3), but not shown to save space. To illustrate pathway plasticity further, the following additional enzymes are shown : L-lactate
dehydrogenase (EC 1.1.1.27) ; pentose phosphate pathway start : glucose 6-phosphate 1-dehydrogenase (EC 1.1.1.49), 6-phosphogluconolactonase (EC 3.1.1.31), phosphogluconate dehydrogenase
(decarboxylating) (EC 1.1.1.44) ; non-phosphorylated Entner–Doudoroff pathway : glucose dehydrogenase (EC 1.1.99.17). Gluconate dehydratase (EC 4.2.1.39), 2-dehydro-3-deoxyglucarate aldolase
(EC 4.1.2.20). Abbreviations : DAP, dihydroxyacetone phosphate ; Fru6P, fructose 6-phosphate ; Fru1,6BP, fructose 1,6-bisphosphate ; G, glyceraldehyde ; G acid, glyceric acid ; Glc6P, glucose 6-
phosphate ; gluconic acid 6P, 6-phosphogluconic acid ; G3P, 3-phosphoglycerate ; G13BP, 1,3-bisphosphoglycerate ; G23BP, 2,3-bisphosphoglycerate ; G2P, 2-phosphoglycerate ; Rib5P, ribulose
5-phosphate.
In contrast with higher organisms, the major E. coli pathway for
glucose transport uses the phosphotransferase system glucose
transporter that uses phosphoenolpyruvate (PEP) as an energy-
rich compound to phosphorylate glucose directly to glucose 6-
phosphate (second line in Scheme 1; this transporter is present in
several other organisms).
If well-known glycolytic enzymes are not found in a species,
the question arises of which alternative enzymes, if any, might
compensate for them. Pyruvate kinase is missing from H. pylori.
Sequence analysis shows that a homologue of PEP synthase is
present in H. pylori (indicated in Scheme 1). If properly adapted,
it could compensate for the lack of pyruvate kinase. Note that
pyruvate kinase is not as resistant to low pH as PEP synthase
[17]. H. pylori has to adapt to the highly acidic environment of
the stomach and several possible species-specific adaptations
of H. pylori have been described recently [18].
The connections of the glycolytic pathway to other parts of
metabolism such as the PPP allow further plasticity (shown in
the centre of the top line of Scheme 1).
Besides detours in transport or by-passes to the standard
glycolytic pathway, more dissimilar alternatives for converting
glucose to pyruvate exist in other organisms (Scheme 1, lower
part). The Entner–Doudoroff pathway is used instead of gly-
colysis in some bacteria [19]. The ATP yield is only 1 mol}mol of
glucose. The advantage of this route is a direct yield of NADPH
for biosynthesis. From biochemical data the non-phosphorylated
Entner–Doudoroff pathway (Scheme 1, bottom) is yet another
alternative route for the conversion of glucose to pyruvate. This
is considered to be an example of palaeometabolism [6]. It is
present, for instance, in some Archaea such as Thermoplasma
acidophilum [20]. The direct conversion of glucose to gluconic
acid is not optimized in this ancient pathway and there is no ATP
yield from glucose.
In summary, after the establishment of a solid knowledge basis
from literature and experimental data (Table 1) and from the
extensive use of sequence and genome analysis, in the present
paper the full repertoire of glycolytic enzymes present in the
analysed organisms is better characterized, including organisms
that are difficult to analyse biochemically such as intracellular
parasites. Furthermore, pathway plasticity is examined and
shows alternative pathways and detours within standard gly-
colysis for various organisms (Scheme 1).
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Table 2 Enzyme families and isoenzymes encoded in the different genomes
Enzyme families from the standard glycolytic pathway, hexose phosphorylation, Entner–Doudoroff pathway, pyruvate dehydrogenase and three alternatives in pyruvate processing are compared.
Closely related enzyme activities including isoenzymes are grouped together to allow easy comparison of their respective species distributions. Enzymes are labelled by their EC number and enzyme
names are given for all enzyme families compared. Seventeen species are compared with the following species codes. SY, Synechocystis sp. PCC6803 (blue-green algae) ; CT, Chlamydia trachomatis.
Spirochaetes : TP, Treponema pallidum ; BB, Borrelia burgdorferi. Gram-positive bacteria : BS, Bacillus subtilis ; TB, Mycobacterium tuberculosis ; MG, Mycoplasma genitalium ; MP, Mycoplasma
pneumoniae. Proteobacteria (Gram-negative bacteria) : EC, Escherichia coli ; HI, Haemophilus influenzae ; HP, Helicobacter pylori. Further bacteria : AQ, Aquifex aeolicus. Archaea : AF, Archaeoglobus
fulgidus ; MJ, Methanococcus jannaschii ; MT, Methanobacterium thermoautotrophicum ; PH, Pyrococcus horikoschii. Eukaryotic species : Y, yeast. Completeness of the upper (hexoses) and lower
(trioses) part of glycolysis as well as the pyruvate dehydrogenase (lipoamide) subunits or the pyruvate formate-lyase path is indicated by ‘ co ’ ; important missing enzyme activities are either
phosphofructokinase (pfk) or pyruvate kinase (pyk). CoT indicates that the upper part of glycolysis is complete, assuming glucose phosphorylation by a suitable transport system. To save space,
the specific enzyme sequences are not listed ; however, genome numbers extended by their respective species code allow the retrieval of each enzyme sequence. Several places where corrections
have been made to the assignment of enzyme families are indicated : *, changes with respect to KEGG ; , changes with respect to published data from genome sequencing efforts ; , changes
with respect to WIT. Our Web page on glycolytic enzymes can be consulted for additional corrections and justification details. Abbreviation : PTS, phosphotransferase system.
Genome number
Species code… SY CT BS TP TB BB EC HI HP MG MP AQ AF MJ MT PH Y
Upper part of glycolysis
2.7.1.2 Glucokinase
(glk family) sll0593 2388 1103
2.7.1.2 Glucokinase
(yajF family) slr0329 glck 0831 0394 0182 1496
2.7.1.2 Glucokinase
(yhc1 family) 0650 3222 0144
2.7.1.2 Yeast type
glucokinase 0505 YCL040W
5.3.1.9 Glucose-6-phosphate
isomerase slr1349 378 pgi 0475 0946 0730 4025 1576 1166 111 0583 – 1605 YBR196C
2.7.1.11 6-Phosphofructo-
kinase (family A) sll1196 205* 0108 3010 0727* 3916 0982 215 0535 1708 YGR240C
2.7.1.11 6-Phosphofructokinase
(second copy of family A) sll0745 207 0542 0020*
2.7.1.11 6-Phosphofructo-
kinase (family B) frub 2029 0630 1723
2.7.1.56 1-Phosphofructo-
kinase 2168 0447 063 0076
4.1.2.13 Fructose-bisphos-
phate aldolase 0363 0445 2925 0524 YKL060C
4.1.2.13 Fructose-bisphos-
phate aldolase (second family) sll0018 fbaa 0662 0176 023 0129 1390
4.1.2.13 Fructose-bisphos-
phate aldolase (class I
type family)
215 2097 0108 400 0579 0082
Completeness co coT co co co co co co pfk coT coT co co
Lower part of glycolysis
5.3.1.1 Triose-phosphate
isomerase slr0783 328 tpi 0537 1438 0055 3919 0678 0194 431 0213 0360 1304 1528 1041 1884 YDR050C
1.2.1.12 Glyceraldehyde
-3-phosphate DH
(phosphorylating) slr0884 505 gapa 0844 1436 0057 1779 0001 0921 301 0410 1065 1732 1146 1009 1830 YJL052W
1.2.1.12 Second family sll1342 gapb 1417 1346
1.2.7.– Oxidoreductase
family 1185 0457
2.7.2.3 Phosphoglycerate
kinase slr0394 693 pgk 0538 1437 0056 2926 0525 1345 300 0411 0118 1146 0641 1042 1218 YCR012W*
5.4.2.1 Phosphoglycerate
mutase (family A) 722 0168 0489 0658 0755 0757 YKL152C
5.4.2.1 Phosphoglycerate
mutase (family B) slr1124 yhfr 2228 4395 1744 YKR043C
5.4.2.1 Phosphoglycerate
mutase (2,3-bisphospho-
glycerate independent
form) * slr1945 pgm 3612 0974 430 0214 0542 1751 1612 1591 0037
4.2.1.11 Phosphopyruvate
hydrolase (enolase) slr0752 587 eno 0817 1023 0337 2779 0932 0154 407 0236 0484 1132 0232 0043 1942 YGR254W
2.7.1.40 Pyruvate kinase
family A) sll0587 332 1617 0348 1854 1573 216 0534 0108 0570
2.7.1.40 Pyruvate kinase
(family F) pyka 1676 YAL038W
2.7.9.2 PEP synthase slr0301 ptsi 0746 1127 1702 0121 2142 0710 0542 1118 0092
Completeness co co co pyk co co co co pyk co co pyk pyk co pyk co co
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Genome number
Species code… SY CT BS TP TB BB EC HI HP MG MP AQ AF MJ MT PH Y
Glucose phosphorylation
2.7.1.69 PTSII IIA
component
ybfs 0559 2417 1711 069 0625
2.7.1.69 PTSII IIBC
component
ybfs 0645 1101 069 0625
2.7.1.69 malX PTS 0645 1621 069 0625
2.7.3.9 PEP protein phos-
phatase (enzyme 1 of the
phosphotransferase system) 336 0558 2416 1712 429 0215 0542
Fructose
2.7.1.4 Fructokinase-
related
slr1448 rbsk 2436 3752 0505 0356 0406 0404 1845 YCR036W
Entner–Doudoroff pathway
4.2.1.12 6-Phosphogluconate
dehydratase 1851 1100
4.1.2.14 2-dehydro 3-deoxy
phosphogluconate aldolase sll0107 kdga 0568 1850 0047 1099
Pyruvate dehydrogenase
1.2.4.1 E1 component
(lipoamide) 2241 0114 1233
1.2.4.1 E1 a subunit slr1934 340 pdha 2497 274 0446 YER178W
1.2.4.1 E1 b subunit  sll1721 246 bfubab 2496 273 0447 YBR221C
2.3.1.12 Dihydrolipoamide
S-acetyltransferase (E2
component) pdhc 2215 0115 1232 272 0448 YNL071W
2.3.1.12 Second copy of E2 sll1841 400 bfmbb 0727 YDR148C
1.8.1.4 Dihydrolipoamide
dehydrogenase slr1096 557 pdhb 0462 0116 1231 271 0449 YFL018C
Alternative pyruvate processing
1.2.2.2 Pyruvate oxidase
(cytochrome) ydap 0871 0476
1.97.1.4 Formate
acetyltransferase
activating enzyme 3138 0902 0179 1861 1450 0808 0345 1391
1.97.1.4 Second copy 0823 0180
2.3.1.54 Formate C-
acetyltransferase
(pyruvate formate-lyase) 0903 0180 1449 0346
2.3.1.54 Second copy 1227 1586
1.1.1.1 Alcohol
dehydrogenase 1241 0024 0743 YGL256W
1.2.7.1 Pyruvate synthase
(subunit A) sll0741 0939 1378 1110 1167 1701 0267 1739 0680
1.2.7.1 Pyruvate synthase
(subunit) B sll0741 0939 1378 1111 1168 1702 0266 1738 0681
1.2.7.1 Pyruvate synthase
(subunit C) sll0741 0939 1378 1108 1169 1699 0269 1740 0678
1.2.7.1 Pyruvate synthase
(subunit D) sll0741 0939 1378 1109 1171a 1700 0268 1740 0679
Algebraic pathway analysis
For a further assessment of the different paths detected or
suggested for glucose in the different organisms (Scheme 1), we
calculate substrate fluxes depending on the enzymic activities
present (‘algebraic pathway analysis ’). This checks the con-
sistency of the different enzyme sets deduced from the biochemical
and genomic analyses. Moreover, it reveals which glycolytic by-
passes are viable, where futile cycles are (often indicating
allosteric regulation of key enzymes involved) and which paths
might efficiently be blocked pharmacologically in different
organisms.
We have developed elementary-mode analysis as a tool for this
analysis [8,9], including specific software (see the Materials and
methods section) [10]. A related approach has been developed by
Mavrovouniotis et al. [21]. Starting from a minimum amount of
necessary information, including knowledge of the stoichiometry
and thermodynamic directionality of reactions, all non-decom-
posable flux distributions (‘elementary flux modes’) at stationary
states can be computed. These can be interpreted as biochemical
pathways or futile cycles in the system.
In particular, alternative routes for glycolysis (Scheme 1, first
line) can be re-examined by applying the method. We give three
examples.
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In Mycoplasma hominis, phosphofructokinase, aldolase and
glucose-6-phosphate dehydrogenase seem to be absent on the
basis of biochemical data [15]. It has been argued [15] that these
species instead channel glucose by the PPP, yielding glycer-
aldehyde 3-phosphate plus ribose for nucleotide biosynthesis.
However, on the assumption that the enzymes of the non-
oxidative PPP are operative, computing the elementary modes of
the combined glycolysis and PPP scheme shows that this is not
sufficient to by-pass the above-mentioned enzymes. This is
indicative of a missing link in the metabolism of Mycoplasma
hominis. One possibility would be the presence of fructose-6-
phosphate phosphoketolase (as found, for example, in Aceto-
bacter xylinum ; see the BRENDA database via http:
}}srs.ebi.ac.uk}srs5bin) and of phosphate acetyltransferase (as
found, for example in E. coli and several Mycoplasma species ; see
the ENZYME database, http:}}www.expasy.ch}enzyme}
enzymejdetails.html). It can be shown that, with these activities,
glucose can indeed be converted into intermediates of the lower
glycolytic pathway (elementary mode 1 in the Appendix). The
presence of these enzymes in Mycoplasma hominis can now be
tested experimentally. Another possibility would be the presence
of enzymic activities phosphorylating sedoheptulose 7-phosphate
and splitting the resulting seduheptulose bisphosphate into
dihydroxyacetone phosphate and erythrose 4-phosphate [10]. In
addition, elementary-mode analysis indicates that for non-gly-
colytic species possessing glucose-6-phosphate dehydrogenase
activity, an elementary mode by-passing phosphofructokinase
via the PPP is available (elementary mode 3 in the Appendix).
Another interesting example is Methanococcus jannaschii, in
which new connections and pathway routes are apparent. All
enzymes of the non-oxidative PPP have been identified in its
genome [22]. In contrast, the two dehydrogenases required for
the oxidative PPP could not be identified, either in the genome or
by biochemical assays. Glycolysis seems to be operative, although
hexokinase, 6-phosphofructokinase, fructose bisphosphate aldol-
ase and phosphoglycerate mutase could not be identified in the
genome [22]. Assuming that these enzymes or alternative enzymes
are present (for instance, there are some indications of ADP-
dependent sugar kinases in Archaea; [22,23]), we have computed
the elementary modes for this system. One of these (elementary
mode 2 in the Appendix) corresponds to the transformation of
glucose 6-phosphate into ribose 5-phosphate, which is required
for nucleotide biosynthesis. Thus the oxidative PPP is not
needed for converting hexoses into pentoses under steady-state
conditions. This is in agreement with results on glucose-6-
phosphate dehydrogenase deficiencies [24].
In summary, algebraic pathway analysis examines admissible
routes through metabolism (Appendix). We applied it here to
inprove our understanding of the function of different organism-
specific sets of glycolytic enzymes. In addition, required enzyme
actitivities can be identified better (the example shown is Myco-
plasma hominis), as well as additional viable flux modes, for
instance involving parts of glycolysis and PPP (the example
shown is M. jannaschi).
Comparative genome analysis of glycolysis
To characterize further the species-specific differences in gly-
colytic enzymes, we now compare in detail the biochemical data
and results and the algebraic pathway analysis with the sets of
enzymes encoded in completely sequenced genomes. Enzyme
families and isoenzymes (often differently allosterically regulated)
become apparent ; subsequently we compare each reaction step
and the whole pathway.
Identifying enzyme and isoenzyme families
The result of a systematic genome sequence search to identify
glycolytic enzymes is shown in Table 2. The following species
and clades are compared (from left to right in Table 2) : Blue-
green algae (Synecchocystis sp.), C. trachomatis, Bacillus subtilis,
Treponema pallidum, Mycobacterium tuberculosis, Borrelia burg-
dorferi, three proteobacteria (including E. coli), Mycoplasma
genitalium and Mycoplasma pneumoniae, the bacterium Aquifex
aeolicus, four Archaea and finally yeast (the only eukaryote). The
resulting enzyme patterns of completeness of glycolysis and by-
passes in the different species are summarized in Figure 1.
However, the different enzyme and isoenzyme families with
their differences in regulation and specificities are shown in Table
2, which also describes their respective variations in sequence
and corresponding structure; genome accession numbers in Table
2 permit the retrieval of the exact amino acid sequence for each
enzyme family member. This also permits a comparison of our
data with published genome sequencing efforts and other
genome-based analyses. Furthermore, with this information,
sequences from newly sequenced genomes can be added much
more easily to the correct glycolytic enzyme family. The classi-
fication of the encoded enzyme activities shown in Table 2 has
been derived by a careful comparison of several approaches as
mentioned in the Materials and methods section and includes
corrections compared with standard databases (KEGG, WIT
and genome sequencing efforts). Nevertheless, our analysis
includes many genome-based predictions. Biochemical analyses
will have to confirm these; related as well as completely new
enzymic activities might become apparent as the biochemical
analysis of the various species proceeds.
Further considerations and comparisons that we made to
evaluate encoded enzyme specificities and family relations as
listed in Table 2 are given, including additional corrections and
justification details, on our glycolytic enzyme Web page (http:
}}www.bork.embl-heidelberg.de}Genome}glycolyticjenzymes).
The analyses included a further, less related glucokinase-like
family as well as details on the polyphosphate glucose phospho-
transferase (EC 2.7.1.63) in Mycobacterium tuberculosis, and
related glycolytic and non-glycolytic enzymic activities such as 2-
keto-3-deoxygluconate kinases (EC 2.7.1.45, involved in pectin
degradation) and gluconate kinases (EC 2.7.1.12), PEP synthases
(EC 2.7.9.2) and pyruvate dikinases (EC 2.7.9.1), dihydroxyacid
dehydratase (EC 4.2.1.9) and 6-phosphogluconate dehydratase
(EC 4.2.1.12) (see our Web page on glycolytic enzymes for
details).
Enzyme and isoenzyme families
Manydifferent families of glycolytic enzymes can be distinguished
(Table 2). E. coli, with its large genome and high adaptability, is
particularly rich in glycolytic enzymes, including several by-
passes. The closely related Haemophilus influenzae shares a large
set of enzymes with E. coli [7]. Alternatives to the E. coli set of
enzyme families are seen in the more distantly related species
(Table 2), such as the use of a class I type aldolase inC. trachomatis
or a yeast-type glucokinase not only in yeast but also in
T. pallidum.
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Figure 1 Pathway alignment for glycolysis, Entner–Doudoroff pathway and pyruvate processing
Enzymes for each pathway part (top ; EC numbers and enzyme subunits are given below these) are compared in 17 organisms and represented as small rectangles. Filled and empty rectangles
indicate the presence and absence respectively of enzyme-encoding genes in the different species listed at the left. Further details are given in the text ; different isoenzymes and enzyme families
are listed in Table 2.
The isoenzymes identified for different organisms and listed in
Table 2 are interesting because they are often regulated
differently. For example, different allosteric activators are known
for the pair 6-phosphofructokinase, family A (6-phosphofructo-
kinase number 1, main 6-phosphofructokinase, activated by any
nucleotide diphosphate, inhibited by PEP) and 6-phosphofructo-
kinase, family B (6-phosphofructokinase number 2, which
supplies only 10% of the activity of 6-phosphofructokinase,
family A, and is inhibited by ATP) or the pair pyruvate kinase,
family F (pyruvate kinase 1, activated by fructose 1,6-bisphos-
phate) and pyruvate kinase, family A (pyruvate kinase II, allo-
sterically activated by AMP and other metabolites ; different
structure, expression and kinetics from those of pyruvate kinase,
family F) on the basis of data from E. coli [25]. A larger adaptive
capacity to changes in pH or oxygen contentmight also be implied
in such duplications for several species (Table 2). Furthermore,
we show that isoenzymes in glycolysis are widespread among pro-
karyotes and are not restricted to eukaryotes. Moreover, some
new cases are suggested in which different allosteric regulation
might be expected (e.g. AQ0542 and AQ1744). The recently
discovered [26] induction of the glyceraldehyde-3-phosphate
ferredoxin oxidoreductase (gapor) during glycolysis in hyperther-
mophilic Pyrococcus furiosus, while repressing the standard
glyceraldehyde-3-phosphate dehydrogenase, is an intriguing
example. Our comparative genome analysis suggests a similar
induction for PH0457 and MJ1185 (glyceraldehyde-3-phosphate
oxidoreductase) where as PH1830 and MJ1146 (glyceraldehyde-
3-phosphate dehydrogenase) are repressed during glycolysis.
Glucokinase
Following the direction of glycolytic flow, we shall next discuss
the enzymes compared in Table 2 from top to bottom, including
clade-specific or species-specific peculiarities. For the different
glucokinases we shall illustrate in more detail the assignment of
the genome-encoded sequences to enzyme families (similar con-
siderations for the other enzyme families listed in Table 2 can be
found on our Web page). The glk glucokinase is the major
glucokinase in E. coli. If the phosphotransferase system
is genetically defective, the presence of this glucokinase gene is
essential for residual growth on glucose [25]. Regarding the yajF
glucokinase family, Angell et al. [26a] have biochemically
measured glucokinase activity for its sequence homologue from
Streptomyces coelicolor. Skarlatos and Dahl [27] did the same for
the B. subtilis glucokinase from the glk family (BSglck in Table
2) and showed by insertional mutagenesis that, in contrast with
the situation in E. coli, this glucokinase is the major one for B.
subtilis. However, some of the proteins of this glucokinase family
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(for example, the E. coli gene product) might function as
repressors in carbohydrate utilization (as they are for example
related to the E. coli xylulose repressor and the E. coli yjcT gene),
with the glucokinase activity being complemented by a regulatory
repressor function. For the third family shown in Table 2, genetic
experiments and sequence analyses suggest that in E. coli, the
preferred substrate for the encoded glucokinase from the yhcI
family is N-acetylmannosamine [28]. Another enzyme (number
3437 in E. coli and annotated as glucokinase) is in fact a
gluconokinase and uses gluconate. An ADP-dependent gluco-
kinase has been characterized in Pyrococcus furiosus [23] (Table
1). Relatives of this might be present in other Archaea. In the
pathogenic T. pallidum a gene encodes an enzyme homologous
with the eukaryotic yeast glucokinase (Table 2). This is likely to
be a horizontal gene transfer from eukaryotes, because pro-
karyotic homologues are far more divergent (see [29] for further
comparisons within this large family of sugar kinases). In
Mycobacteria a polyphosphate glucokinase (EC 2.7.1.63) is also
present.
Upper part of glycolysis (processing of hexoses)
Enzymes for this part of glycolysis seem to be missing from
several Archaean species. In contrast, the bacterial species are in
most cases relatively complete in this part ; the absence of 6-
phosphofructokinase in the pathogenic Helicobacter pylori is an
exception. 6-Phosphofructokinase appears in two different iso-
enzyme families, A and B. The fructose bisphosphate aldolase
gene found in C. trachomatis (CT215) encodes a class I fructose
bisphosphate aldolase that has recently been characterized bio-
chemically [30]. Homologues, including Archaean genes, are
given in Table 2. Moreover, note that in Table 1 there are some
additional glycolytic activities measured in Methanococcus mari-
paludis and P. furiosus for which genome counterparts have not
yet been identified.
Lower part of glycolysis
This route is shown to be operative in many species (Table 2;
Figure 1). Four enzymes in the lower part of glycolysis are
conserved in all species (Table 2) ; phosphoglyceromutase is also
present in all species but uses different variants. No gene has been
found for pyruvate kinase in 5 of the 17 species considered.
Perhaps this indicates the presence of yet another undetected
enzyme that has displaced the ‘classical ’ form. Note that PEP-
driven transport systems for glucose import and phosphorylation
also allow PEP to be turned into pyruvate without requiring
pyruvate kinase [31]. A third alternative is the use of pyruvate
dikinase (present in Mycobacterium tuberculosis and T. pallidum).
In the remaining species, completion of the lower part of
glycolysis is possible because several versions of phospho-
glyceromutase and pyruvate kinase are identified.
Glucose transport with phosphorylation
A range of specific transporters is able to phosphorylate glucose,
alleviating the need for a hexokinase or glucokinase for instance
in compact genomes (Mycoplasmae). Cross-species comparison
confirms that the E. coli-like protein-N(PI)-phosphohistidine-
sugar phosphotransferases as well as the E. coli-type phospho-
enolpyruvate protein phosphatase have a limited species range
(Table 2). A range of other sugar transporters are present.
Fructokinase is one example (note that in E. coli the specific
fructokinase is plasmid-borne; the chromosomal enzyme is a
ribokinase with broader specificity). Another entry point for
fructose into glycolysis is the formation of fructose 1,6-bis-
phosphate by the action of the fruK gene product (i.e. by the 1-
phosphofructokinase instead of the closely related 6-phospho-
fructokinase; Table 2).
Entner–Doudoroff pathway
This is functional in E. coli and H. pylori. In several other species,
genes encoding 2-dehydro-3-deoxyphosphogluconate aldolase
(EC 4.1.2.14) are present (Table 2) (some potential phospho-
gluconate dehydratase genes are listed on our Web site).
Pyruvate processing
The specific pyruvate dehydrogenase repressor used in E. coli is
not found in the other species (Table 2). Pyruvate dehydrogenase
(lipoamide) subunits are missing from Borrelia, Helicobacter,
T. pallidum, Aquifex and Archaea. Instead, these species, except
Borrelia, use a pyruvate synthase (EC 1.2.7.1) for this reaction
[32]. Furthermore, some species harbour pyruvate dehydrogenase
(cytochrome), EC 1.2.2.2, which decarboxylates pyruvate to
acetate and carbon dioxide with a lower energetic efficiency than
pyruvate dehydrogenase (lipoamide), EC 1.2.4.1, or the pyr-
uvate formate-lyase path, which converts pyruvate to acetyl-
CoA under strict anaerobic conditions [composed of the pyruvate
formate-lyase-activating enzyme (EC 1.97.1.4)] and formate
acetyltransferase (EC 2.3.1.54) ; the further path uses for instance
alcohol dehydrogenase}acetaldehyde dehydrogenase).
Comparing glycolytic pathways between species
Glycolysis is present to some extent across all species (Figure 1),
which confirms that it is one of the most basic pathways in life.
The lower part of glycolysis (trioses) is best conserved. Different
enzymes of the upper part of glycolysis are missing from Archaea.
The first phosphorylation step provided by glucokinase or
hexokinase in many organisms seems to be replaced by transport
phosphorylation in some species. The lower part of glycolysis
also serves anabolic and conversion functions in amino acid and
carbohydrate metabolism. It has more stringent requirements for
being maintained. It seems to be the older part of this metabolic
pathway. Its widespread distribution suggests that it was present
even in the last common ancestor. The Entner–Doudoroff
pathway (Scheme 1), although generally believed to be a more
ancient catabolic route for glucose than glycolysis [6,33], is not as
well conserved. It is present only in the Gram-negative bacteria
in our comparison. Both the phosphorylated and the non-
phosphorylated Entner–Doudoroff pathways have been de-
scribed in several other Archaea and Eubacteria (Scheme 1) [33]
and additional non-homologous sequences might have escaped
our detection. These observed as well as potential variations in
the presence of different Entner–Doudoroff enzymes again in-
dicate that the pathway need not be well conserved. The
secondary loss of an inefficient old pathway is another possibility
to explain its lack of conservation, but it seems not to be that
inefficient as it successfully co-exists with glycolysis in several
species.
Pyruvate dehydrogenase (lipoamide) is often used in Eubac-
teria. Its anaerobic counterpart in Archaea is pyruvate synthase;
pyruvate formate-lyase is also often present in Archaea. E. coli,
an adaptation generalist with its large genome, harbours all three
alternatives ; as for the parasites, B. burgdorferi has none and T.
pallidum (probably) has only the pyruvate synthase (EC 1.2.7.1).
Correlations between the different metabolic steps analysed
exist : for instance, glycolysis is one of the main generators of
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pyruvate in the cell ; for all of the organisms analysed, if pyruvate
dehydrogenase is present, glycolysis is also present. Similarly a
lack of pyruvate kinase is correlated with a lack of pyruvate
dehydrogenase (Figure 1). However, alternative by-passes
(Scheme 1) for each of the steps as well as the patterns for
Archaea (Figure 1) or the different pyruvate oxidoreductases
[counterpart inArchaea is pyruvate synthase (EC1.2.7.1)] (Figure
1) show that such metabolic correlations are not strict.
In summary, comparative genome analysis identifies glycolytic
isoenzymes such as different versions of phosphoglycerate mutase
preferentially used in Archaea and bacteria or different types of
glucokinase. Species-specific enzymes become apparent, such as
class I aldolases in Chlamydia and Archaea, the absence of
enzymes (e.g. the lack of 6-phosphofructokinase and pyruvate
kinase in H. pylori and several Archaea) and by-passes such as
Entner–Doudoroff enzymes in some species (Table 2). Pyruvate
dehydrogenase (oxygen might be present in the cell ; many
Eubacteria) and pyruvate synthase (anaerobic lifestyle ; Archaea)
are good examples of observed phenotypic adaptations. The
variance in glycolysis is highlighted by the fact that none of the
species compared show the same pattern of enzymes present,
with the exception of the closely related Mycoplasma species
(Figure 1).
Conclusion
We show that even the simple and basic pathway of glycolysis
has a high plasticity and versatility both in a single species (e.g.
E. coli) and in a multi-genome comparison (Scheme 1).
Currently the adaptability of organisms seems to be under-
estimated if only the textbook pathway is considered. Except for
the two Mycoplasma species, no two species encode the same
pattern of glycolytic enzymes (Figure 1). We find by elementary-
mode analysis that even the blocking of central enzymes such as
aldolase as an antibiotic strategy might not be effective in some
pathogens because alternative substrate fluxes have to be con-
sidered (Appendix). We reveal different species-specific sets of
isoenzymes (e.g. three types of phosphoglyceromutase), alterna-
tive enzymes (such as pyruvate dehydrogenase and pyruvate
synthase) and by-passes (e.g. Entner–Doudoroff) by combining
biochemical data (Table 1) with comparative genome analysis
(Table 2).
The differences identified can now be examined further bio-
chemically. Several are interesting for medicine and drug design,
such as parasite-specific adaptations in Mycoplasma and H.
pylori, the different sugar transporters, or the polyphosphate
glucokinase in Mycobacterium tuberculosis. Starting points for
metabolic engineering are also apparent, e.g. a higher yield of
NADPH by expressing enzymes of the Entner–Doudoroff path-
way or for the improvement of other product-to-substrate ratios
in a micro-organism.
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APPENDIX
Elementary-mode analysis of by-passes in glycolysis
Looking at the different sets of glycolytic enzymes present in
various organisms, it is interesting to identify substrate flux
modes that work despite the lack of textbook glycolytic enzymes.
In algebraic pathway analysis, an algorithm systematically cal-
culates all elementary substrate flux modes for a given set of
enzymes. Three examples are listed with the use of the algorithm
and programs given in the Materials and methods section. We
limit our analysis to glycolysis and the PPP, starting at glucose
6-phosphate (Glc6P) and ending at 1,3-bisphosphoglycerate
(G13BP) for reasons of simplicity. Note that the conversion of
G13BP into pyruvate yields 2 mol of ATP. The elementary flux
modes are idealized situations; any observed substrate flux dis-
tribution in a living cell is a linear combination of the few
elementary flux modes calculated from the set of enzymes present.
In what follows, a minus sign indicates that a reaction proceeds
in the opposite direction; numbers correspond to the relative
fluxes carried by the different reactions catalysed.
Elementary mode 1
How could Mycoplasma hominis convert glucose despite the lack
of glucose-6-phosphate dehydrogenase and 6-phosphofructo-
kinase? One elementary flux mode calculated for the species-
specific (see the text) modified set of enzymes yields the following
succession of enzymes as a possible solution: 2 phospho-
glucoisomerase, firibose-5-phosphate isomerase, xylulose-5-
phosphate epimerase, fitransketolase reaction I, 2 transketolase
reaction II, fitransaldolase, 3 fructose-6-phosphate phospho-
ketolase, fi3 phosphate acetyltransferase, 2 glyceraldehyde-3-
phosphate dehydrogenase.
Elementary mode 2
An elementary flux mode probably operative in Methanococcus
jannaschii converts glucose 6-phosphate into ribose 5-phos-
phate without the requirement of the oxidative PPP by using the
Received 22 March 1999/1 June 1999 ; accepted 15 July 1999
following enzyme reactions in succession: 5 phosphoglucoiso-
merase, fructose-1,6-bisphosphate aldolase, triose-phosphate
isomerase, 4 ribose-5-phosphate isomerase, fi4 xylulose-5-phos-
phate epimerase, fi2 transketolase reaction I, fi2 transketolase
reaction II, fi2 transaldolase, 6-phosphofructokinase.
Elementary mode 3
The following flux mode can process glucose if phospho-
fructokinase is absent ; it uses PPP enzymes for the by-pass (as
depicted in Scheme 1) : fi2 phosphoglucoisomerase, glycer-
aldehyde-3-phosphate dehydrogenase, 3 glucose-6-phosphate
dehydrogenase, 3 phosphogluconolactonase, 3 gluconate-6-
phosphate dehydrogenase, ribose-5-phosphate isomerase, 2
xylulose-5-phosphate epimerase, transketolase reaction I, trans-
aldolase, transketolase reaction II.
Reaction yields of the modes
The overall reaction yields calculated for these elementary modes
test the results of the algorithm and prove that each set of
enzymes achieves what was claimed (see parenthetical state-
ments).
For elementary mode 1 (glucose 6-phosphate is channelled into
the lower part of glycolysis) :
3CoA›2NAD+›2Glc6P! 3Ac-CoA›2NADH›2G13BP
For elementary mode 2 (glucose 6-phosphate is efficiently
converted into ribose 5-phosphate) :
ATP›5Glc6P!ADP›6R5P
where R5P is ribose 5-phosphate.
For elementary mode 3 (glucose 6-phosphate is channelled
into the lower part of glycolysis by a different route) :
Glc6P›NAD+›6NADP!
NADH›6NADPH›3CO
#
›G13BP
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